Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder

Clinical trial NCT01145313 · COMPLETED

Trial details

NCT number: NCT01145313
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Depressive Disorder, Major

Start date: 2007-10-01
Primary completion: 2010-06-01
Enrollment: 501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.